摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(1-Adamantyl)-3-[(4-methylpiperazin-1-yl)methyl]-1,3,4-thiadiazole-2-thione | 1257344-16-3

中文名称
——
中文别名
——
英文名称
5-(1-Adamantyl)-3-[(4-methylpiperazin-1-yl)methyl]-1,3,4-thiadiazole-2-thione
英文别名
——
5-(1-Adamantyl)-3-[(4-methylpiperazin-1-yl)methyl]-1,3,4-thiadiazole-2-thione化学式
CAS
1257344-16-3
化学式
C18H28N4S2
mdl
——
分子量
364.579
InChiKey
YOMVFKPFJPABGC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    24
  • 可旋转键数:
    3
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    79.5
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    N-甲基哌嗪聚合甲醛5-(1-adamantyl)-1,3,4-3H-thiadiazoline-2-thione乙醇 为溶剂, 反应 26.0h, 以36%的产率得到5-(1-Adamantyl)-3-[(4-methylpiperazin-1-yl)methyl]-1,3,4-thiadiazole-2-thione
    参考文献:
    名称:
    Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives
    摘要:
    New 1-adamanyl-1,3,4-thiadiazole derivatives namely, 5-(1-adamantyl)-1,3,4-thiadiazoline-2-thione 3, 5-(1-adamantyl)-3-(benzyl- or 4-substituted benzyl)-1,3,4-thiadiazoline-2-thione 4a-d, 5-(1-adamantyl)-3-(4-substituted-1-piperazinylmethyl)-1,3,4-thiadiazoline-2-thiones 5a-c, 2-[5-(1-adamantyl)2-thioxo-1,3,4-thiadiazolin-3-yl]acetic acid 7, (+/-)-2-[5-(1-adamantyl)-2-thioxo-1,3,4-thiadiazolin-3-yl] propionic acid 9, 3-[5-(1-adamantyl)-2-thioxo-1,3,4-thiadiazolin-3-yl]propionic acid 11, N-[5-(1-adamantyl)-1,3,4-thiadiazol-2-yl]-N'-arylthioureas 15a-c and 5-(1-adamantyl)-1,3,4-thiadiazoline-2-one 16, were synthesized and tested for in vitro activities against a panel of Gram-positive and Gram-negative bacteria and the yeast-like pathogenic fungus Candida albicans. Compounds 7, 9, 15b and 15c displayed marked activity against the tested Gram-positive bacteria, while compound 3 was highly active against the tested Gram-negative bacteria. Compounds 4b, 7 and 15c were weakly or moderately active against C albicans. In addition, the in vivo anti-inflammatory activity of the synthesized compounds was determined using the carrageenan-induced paw oedema method in rats. The propionic acid derivative 9 produced good dose-dependent anti-inflammatory activity. (C) 2010 Elsevier Masson SAS. All rights reserved,
    DOI:
    10.1016/j.ejmech.2010.08.007
点击查看最新优质反应信息

文献信息

  • Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives
    作者:Adnan A. Kadi、Ebtehal S. Al-Abdullah、Ihsan A. Shehata、Elsayed E. Habib、Tarek M. Ibrahim、Ali A. El-Emam
    DOI:10.1016/j.ejmech.2010.08.007
    日期:2010.11
    New 1-adamanyl-1,3,4-thiadiazole derivatives namely, 5-(1-adamantyl)-1,3,4-thiadiazoline-2-thione 3, 5-(1-adamantyl)-3-(benzyl- or 4-substituted benzyl)-1,3,4-thiadiazoline-2-thione 4a-d, 5-(1-adamantyl)-3-(4-substituted-1-piperazinylmethyl)-1,3,4-thiadiazoline-2-thiones 5a-c, 2-[5-(1-adamantyl)2-thioxo-1,3,4-thiadiazolin-3-yl]acetic acid 7, (+/-)-2-[5-(1-adamantyl)-2-thioxo-1,3,4-thiadiazolin-3-yl] propionic acid 9, 3-[5-(1-adamantyl)-2-thioxo-1,3,4-thiadiazolin-3-yl]propionic acid 11, N-[5-(1-adamantyl)-1,3,4-thiadiazol-2-yl]-N'-arylthioureas 15a-c and 5-(1-adamantyl)-1,3,4-thiadiazoline-2-one 16, were synthesized and tested for in vitro activities against a panel of Gram-positive and Gram-negative bacteria and the yeast-like pathogenic fungus Candida albicans. Compounds 7, 9, 15b and 15c displayed marked activity against the tested Gram-positive bacteria, while compound 3 was highly active against the tested Gram-negative bacteria. Compounds 4b, 7 and 15c were weakly or moderately active against C albicans. In addition, the in vivo anti-inflammatory activity of the synthesized compounds was determined using the carrageenan-induced paw oedema method in rats. The propionic acid derivative 9 produced good dose-dependent anti-inflammatory activity. (C) 2010 Elsevier Masson SAS. All rights reserved,
查看更多